CA3064357A1 - Vaccine comprising clostridium toxoids - Google Patents

Vaccine comprising clostridium toxoids Download PDF

Info

Publication number
CA3064357A1
CA3064357A1 CA3064357A CA3064357A CA3064357A1 CA 3064357 A1 CA3064357 A1 CA 3064357A1 CA 3064357 A CA3064357 A CA 3064357A CA 3064357 A CA3064357 A CA 3064357A CA 3064357 A1 CA3064357 A1 CA 3064357A1
Authority
CA
Canada
Prior art keywords
toxoid
difficile
immunogenic composition
vaccine
perfringens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3064357A
Other languages
English (en)
French (fr)
Inventor
Xavier Gibert Perez
Marta SITJA ARNAU
Original Assignee
Hipra Scientific SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hipra Scientific SL filed Critical Hipra Scientific SL
Publication of CA3064357A1 publication Critical patent/CA3064357A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA3064357A 2017-06-09 2018-06-07 Vaccine comprising clostridium toxoids Pending CA3064357A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17382358.4 2017-06-09
EP17382358 2017-06-09
PCT/EP2018/065025 WO2018224595A1 (en) 2017-06-09 2018-06-07 Vaccine comprising clostridium toxoids

Publications (1)

Publication Number Publication Date
CA3064357A1 true CA3064357A1 (en) 2018-12-13

Family

ID=59078007

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3064357A Pending CA3064357A1 (en) 2017-06-09 2018-06-07 Vaccine comprising clostridium toxoids

Country Status (8)

Country Link
US (1) US11154605B2 (https=)
EP (1) EP3634480A1 (https=)
JP (2) JP7349366B2 (https=)
BR (1) BR112019024412A2 (https=)
CA (1) CA3064357A1 (https=)
MX (1) MX388528B (https=)
WO (1) WO2018224595A1 (https=)
ZA (1) ZA201907715B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202509058A (zh) * 2023-08-24 2025-03-01 法商西華動物藥品股份有限公司 抗豬感染之多價疫苗

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY149604A (en) * 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine
AR089797A1 (es) 2012-01-27 2014-09-17 Merck Sharp & Dohme Vacunas contra clostridum difficile que comprenden toxinas recombinantes
KR20150133770A (ko) 2013-03-15 2015-11-30 사노피 파스퇴르 인코포레이티드 톡소이드, 조성물 및 관련 방법

Also Published As

Publication number Publication date
JP2020522471A (ja) 2020-07-30
WO2018224595A1 (en) 2018-12-13
MX2019013779A (es) 2020-01-13
EP3634480A1 (en) 2020-04-15
JP2023113631A (ja) 2023-08-16
MX388528B (es) 2025-03-20
ZA201907715B (en) 2024-09-25
JP7349366B2 (ja) 2023-09-22
US20200188500A1 (en) 2020-06-18
US11154605B2 (en) 2021-10-26
BR112019024412A2 (pt) 2020-07-14

Similar Documents

Publication Publication Date Title
TWI602575B (zh) 豬肺炎黴漿菌疫苗
US11103569B2 (en) Vaccine for protection against Streptococcus suis
AU2015310932B2 (en) Attenuated bovine coronavirus and related vaccines
US11696944B2 (en) Vaccine for protection against Streptococcus suis
US10751403B2 (en) Vaccine for protection against Streptococcus suis
US12295999B2 (en) Vaccine for protection against Streptococcus suis
US12383610B2 (en) Vaccine for protection against Streptococcus suis serotype 9, sequence type 16
US11154605B2 (en) Vaccine comprising Clostridium toxoids
Dellagostin et al. TbpBY167A-based vaccine is safe in pregnant sows and induces high titers of maternal derived antibodies that reduce Glaesserella parasuis colonization in piglets
EP0651609A1 (en) Pasteurella multocida toxoid vaccines
CA2866199A1 (en) Novel veterinary vaccine
RU2802072C2 (ru) Вакцина для защиты от streptococcus suis
WO2025040792A1 (en) Multivalent vaccine against swine infections
US20220339276A1 (en) A vaccine for protection against streptococcus suis

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220927

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - STANDARD

Year of fee payment: 7

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250530

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250530

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250818

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250818

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D164 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: RESPONSE TO NOTICE OF ALLOWANCE

Effective date: 20251128

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-2-4-D10-D22-D143 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRE-GRANT

Effective date: 20260307

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260307